• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » SIRO Clinpharm named Indian CRO of the Year 2012

SIRO Clinpharm named Indian CRO of the Year 2012

October 1, 2012
CenterWatch Staff

SIRO Clinpharm, a drug development solutions provider, has been awarded the 'Indian CRO of the Year 2012' by Frost & Sullivan, a global growth partnership and consulting firm.

The award was received by Gopakumar Menon, CEO, SIRO Clinpharm on behalf of the employees. "I am proud to receive this award as an ambassador of exceptional professionals across three continents, whose daily pursuit of excellence has resulted in SIRO Clinpharm receiving this award for two consecutive years," he said.

Ajaykumar Sharma, associate director of pharma and biotech, South Asia and Middle East, Frost & Sullivan, added, "With all the regulatory challenges which had taken off the sheen from the Indian CRO industry in the last few years, it is amazing to see a company repeating this feat for the second year in a row.”

The award is a testimony to SIRO Clinpharm's commitment in supporting its stakeholders through ethical, transparent and best-in-class services.

"As the Indian markets open to the western world, there are a number of challenges we face not just as a company but as an industry,” said Vatsal Shah, head of medical writing and pharmacovigilance, SIRO. “However, we have been able to convert these challenges into opportunities by ensuring process excellence, improving service delivery and focusing on training and development of our resources—thus, delivering a spectrum of services that is unique to the industry.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing